Xartus CH Tablet is a combination antihypertensive medication containing Telmisartan 40 mg and Chlorthalidone 12.5 mg. Telmisartan is an angiotensin II receptor antagonist that selectively blocks the binding of angiotensin II to the AT1 receptor, thereby inhibiting vasoconstriction and aldosterone secretion, leading to vasodilation and reduction in blood pressure. Chlorthalidone is a thiazide-like diuretic that promotes sodium and water excretion by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, contributing to decreased blood volume and further lowering of blood pressure. The synergistic effect of these two agents provides effective management of hypertension, reducing the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure. Xartus CH is indicated for patients who require combination therapy for blood pressure control when monotherapy is insufficient. It is essential to monitor renal function, electrolytes, and blood pressure regularly during treatment. Caution is advised in patients with renal or hepatic impairment, electrolyte imbalances, or hypersensitivity to sulfonamides. Xartus CH should be used under medical supervision, with dosage adjustments based on therapeutic response and tolerability. Adherence to prescribed therapy and lifestyle modifications enhances treatment outcomes.